Ganirelix has potential applications in all conditions where reduced sex-steroid secretion is advantageous, including assisted reproduction protocols, advanced prostatic carcinoma, benign prostatic hyperplasia, uterine fibroids, and endometriosis. It has the potential therapeutic advantage over GnRH agonists of avoiding the initial stimulation of sex-steroid secretion. This will avoid the disease flare produced by agonists in prostatic carcinoma (Cook and Sheridan, 2000) and reduce the time over which it must be administered in assisted reproduction protocols.It is producing a similar pregnancy rate to that obtained using leuprorelin but with fewer injections and a shorter protocol.
A: We are an GMP approved manufacturer specialized in growth peptides products, OEM is available.
Q2. What is your MOQ ?
A: We support trial order, 10pcs/box is min.
Q3. What is your delivery date?
A: Can be shipped within 2days after payment.
Q4. What is your payment term?
A: Can be discussed, trasfer/cash/USD/RMB etc.
Q5. Which country is your products sold?
A: Our products sold worldwide expecially to Europe, North America and South America.
Q6. How quality guaranteed?
A: We provide testing report, customers can test our products as well, if there is quality issue, we can provide exchange for free.